Related Experiment Video
Updated: May 11, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction
Jianqin Ye1, Yerem Yeghiazarians
1*Division of Cardiology, Department of Medicine; †Cardiovascular Research Institute; and ‡Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA.
Abstract:
Various stem cell types have been tested for regenerating damaged myocardium after myocardial infarction. However, the results of clinical trials have not been consistent, with only some of the trials reporting small improvements in cardiac function. It seems that engraftment and survival of injected cells is limited and transplanted stem cells either do not differentiate into cardiac cells or differentiate into only limited number of cardiac cells. The exact mechanism(s) of cardiac functional improvement by cell therapy are unclear, but paracrine effect may play a central role. The resident cardiac progenitor cells identified within the adult myocardium have distinct advantages over other stem cell types for cardiac cell therapy, as they are likely precommitted to the cardiovascular fate. However, isolating and expanding these cells from cardiac biopsies is a challenge. More recently, direct reprogramming of fibroblasts into cardiomyocytes has given new hope for myocardial regeneration. Here we will review different stem cells used in cardiac cell therapy with a focus on the native cardiac progenitor cells and briefly outline future directions of cardiac cell therapy.
Insights
Stem cell therapy for heart attack shows limited success due to poor cell survival. Native cardiac progenitor cells and direct reprogramming offer promising avenues for myocardial regeneration.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
Background:
- Myocardial infarction (MI) leads to damaged heart muscle.
- Current stem cell therapies for MI show inconsistent clinical results.
- Limited cell engraftment, survival, and differentiation hinder efficacy.
Purpose of the Study:
- To review stem cell types used in cardiac cell therapy.
- To focus on native cardiac progenitor cells for myocardial regeneration.
- To explore direct reprogramming of fibroblasts into cardiomyocytes.
Main Methods:
- Literature review of stem cell applications in cardiac repair.
- Analysis of challenges in stem cell engraftment and differentiation.
- Discussion of paracrine effects in cell therapy mechanisms.
Main Results:
- Inconsistent outcomes in clinical trials for MI regeneration.
- Paracrine effects are a potential key mechanism for cardiac functional improvement.
- Native cardiac progenitor cells offer advantages but face isolation challenges.
Conclusions:
- Cardiac cell therapy requires improved cell survival and differentiation strategies.
- Native cardiac progenitor cells and direct reprogramming are promising for future myocardial regeneration.
- Further research is needed to optimize cell-based cardiac repair.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Adult Stem Cells

